Related Experiment Video
Updated: Feb 16, 2026
11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
20.2K
Scar Homogenization in Atrial Fibrillation Ablation: Evolution and Practice
Aditya Saini1, Jose F Huizar1, Alex Tan1
1Division of Cardiology, Hunter Holmes McGuire VAMC and Virginia Commonwealth University, Richmond, VA.
Journal of Atrial Fibrillation
|December 19, 2017
Summary
Atrial fibrillation (AF) ablation, specifically pulmonary vein isolation (PVI), is a key treatment for symptomatic paroxysmal AF unresponsive to medication. This procedure targets pulmonary vein triggers, offering a preferred rhythm control strategy.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Atrial fibrillation (AF) is a common arrhythmia.
- Pharmacological treatments for AF have limitations.
- Pulmonary vein triggers are a primary cause of AF.
Purpose of the Study:
- To highlight atrial fibrillation (AF) ablation as a primary treatment.
- To emphasize pulmonary vein isolation (PVI) as the cornerstone therapy.
- To discuss AF ablation for patients refractory to antiarrhythmic drugs.
Main Methods:
- Pulmonary vein isolation (PVI) procedure.
- Catheter ablation techniques.
- Electrophysiological mapping to identify triggers.
Main Results:
- PVI is effective for rhythm control in paroxysmal AF.
- AF ablation is preferred over antiarrhythmic medication in select cases.
- Successful PVI targets the pulmonary vein triggers initiating AF.
Conclusions:
- Pulmonary vein isolation (PVI) is the established therapy for drug-refractory symptomatic paroxysmal atrial fibrillation (AF).
- AF ablation provides a crucial rhythm control option for patients intolerant to antiarrhythmic medications.
